Show notes
The conversation delves into the billion-dollar Alzheimer's fraud, focusing on the Amyloid Cascade Hypothesis, the Lainar scandal, the pharmaceutical industry's pursuit of anti-amyloid drugs, the reframing of Alzheimer's disease, the role of metabolic interventions in brain health, and the failure of the system in addressing Alzheimer's research.TakeawaysScientific FraudAlzheimer's ResearchMetabolic InterventionsChapters00:00 The Amyloid Cascade Hypothesis08:26 Pharmaceutical Industry and Anti-Amyloid Drugs16:14 The Failure of the System



